AORT
Artivion, Inc.
Medical Devices · Healthcare · United States
28.41
close · 2026-08-13
value
32
cheaper than peers32
quality
70
stronger fundamentals70
ranked against
Medical Devices
value
quality
55 peerswide variation
Value inputs
| measure | company | vs peers |
| price to book | 3.10× | 56 |
| earnings yield, 2 years ago | -2.6% | 55 |
| earnings yield, latest year | 0.7% | 55 |
| price to sales | 2.81× | 53 |
| cash flow yield, 3 years ago | -1.1% | 45 |
| earnings yield, 1 year ago | -1.1% | 45 |
| earnings yield, 3 years ago | -1.7% | 35 |
| forward P/E | 36.42× | 26 |
| cash flow yield, latest year | 0.1% | 25 |
| cash flow yield, 1 year ago | 0.8% | 25 |
| cash flow yield, 2 years ago | 0.7% | 25 |
| EV to EBITDA | 23.98× | 20 |
12 of 12 measures available
Quality inputs
| measure | company | vs peers |
| revenue growth | 17.5% | 70 |
| return on equity | 3.1% | 61 |
| operating margin | 5.2% | 55 |
| debt to equity | 57.3% | 54 |
4 of 4 measures available
Facts
| market cap | $1B |
| free cash flow | -$7.3M |
| employees | 1,800 |
| first trade | 1993-02-12 |
| next earnings | 2026-08-06 |
| fundamentals updated | 2026-08-06 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | 0.21 | -0.32 | -0.75 | -0.48 |
| free cash flow | $839,000 | $11.0M | $9.1M | -$15.9M |
| net income | $9.8M | -$13.4M | -$30.7M | -$19.2M |
| revenue | $441.3M | $388.5M | $354.0M | $313.8M |
| unusual items | $4.3M | -$3.7M | $14.3M | $0 |